Cargando…

Proton Pump Inhibitor-Induced Remission of Lymphocytic Esophagitis

Lymphocytic esophagitis is a chronic condition that has been described in the literature; however, there is little information describing its characteristics and treatment. We present a case of lymphocytic esophagitis that was identified following food impaction. Repeat esophagogastroduodenoscopy (E...

Descripción completa

Detalles Bibliográficos
Autores principales: Sloan, Joshua, Sandhu, Naemat, Miick, Ronald, Govil, Yogesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American College of Gastroenterology 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5226190/
https://www.ncbi.nlm.nih.gov/pubmed/28119946
http://dx.doi.org/10.14309/crj.2016.168
_version_ 1782493622039478272
author Sloan, Joshua
Sandhu, Naemat
Miick, Ronald
Govil, Yogesh
author_facet Sloan, Joshua
Sandhu, Naemat
Miick, Ronald
Govil, Yogesh
author_sort Sloan, Joshua
collection PubMed
description Lymphocytic esophagitis is a chronic condition that has been described in the literature; however, there is little information describing its characteristics and treatment. We present a case of lymphocytic esophagitis that was identified following food impaction. Repeat esophagogastroduodenoscopy (EGD) with biopsy showed a marked decrease in lymphocytic infiltration after a 6-week course of twice-daily high-dose proton pump inhibitor (PPI). After initiation of the high-dose PPI regimen, the patient had no further episodes of dysphagia or food impaction. We propose that treating lymphocytic esophagitis with twice-daily PPI can improve symptoms and show histologic evidence of improvement.
format Online
Article
Text
id pubmed-5226190
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher American College of Gastroenterology
record_format MEDLINE/PubMed
spelling pubmed-52261902017-01-24 Proton Pump Inhibitor-Induced Remission of Lymphocytic Esophagitis Sloan, Joshua Sandhu, Naemat Miick, Ronald Govil, Yogesh ACG Case Rep J Case Report Lymphocytic esophagitis is a chronic condition that has been described in the literature; however, there is little information describing its characteristics and treatment. We present a case of lymphocytic esophagitis that was identified following food impaction. Repeat esophagogastroduodenoscopy (EGD) with biopsy showed a marked decrease in lymphocytic infiltration after a 6-week course of twice-daily high-dose proton pump inhibitor (PPI). After initiation of the high-dose PPI regimen, the patient had no further episodes of dysphagia or food impaction. We propose that treating lymphocytic esophagitis with twice-daily PPI can improve symptoms and show histologic evidence of improvement. American College of Gastroenterology 2016-12-21 /pmc/articles/PMC5226190/ /pubmed/28119946 http://dx.doi.org/10.14309/crj.2016.168 Text en Copyright © Sloan et al. This is an open-access article. This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/
spellingShingle Case Report
Sloan, Joshua
Sandhu, Naemat
Miick, Ronald
Govil, Yogesh
Proton Pump Inhibitor-Induced Remission of Lymphocytic Esophagitis
title Proton Pump Inhibitor-Induced Remission of Lymphocytic Esophagitis
title_full Proton Pump Inhibitor-Induced Remission of Lymphocytic Esophagitis
title_fullStr Proton Pump Inhibitor-Induced Remission of Lymphocytic Esophagitis
title_full_unstemmed Proton Pump Inhibitor-Induced Remission of Lymphocytic Esophagitis
title_short Proton Pump Inhibitor-Induced Remission of Lymphocytic Esophagitis
title_sort proton pump inhibitor-induced remission of lymphocytic esophagitis
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5226190/
https://www.ncbi.nlm.nih.gov/pubmed/28119946
http://dx.doi.org/10.14309/crj.2016.168
work_keys_str_mv AT sloanjoshua protonpumpinhibitorinducedremissionoflymphocyticesophagitis
AT sandhunaemat protonpumpinhibitorinducedremissionoflymphocyticesophagitis
AT miickronald protonpumpinhibitorinducedremissionoflymphocyticesophagitis
AT govilyogesh protonpumpinhibitorinducedremissionoflymphocyticesophagitis